Our results coincide with the reported anti-proliferative effect of Luzp1 downregulation in colorectal cancer cells (Poel et al., 2019) and the reported increase in proliferation due to Luzp1 upregulation in uterine fibroids (Edwards et al., 2019). This evidence concerns the gene LUZP1 and colorectal cancer.